EUVIMEDEUVIMED entdecken
Leitlinie

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3

Rahul Banerjee iD, Hans Messersmith iD, Mohammad Ebraheem iD, Shaji Kumar iD, Rahul Seth, Latha Subramanian, Samer Al Hadidi iD, Saurabh Zanwar iD, Matthew C Cheung, Benjamin Derman iD, Lisa K Hicks iD

Journal of Clinical Oncology · 30.09.2026

DOI: 10.1200/jco-26-02399 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Oncology, online erschienen am 30.09.2026. Verfasst von Rahul Banerjee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only). Updates are published regularly and can be found on the ASCO Publications website .

Autor:innen und Institutionen

  • Fred Hutchinson Cancer Center, Seattle, WA.
  • American Society of Clinical Oncology (ASCO), Alexandria, VA.
  • Kuwait Cancer Control Center, Kuwait City, Kuwait.
  • Mayo Clinic, Rochester, MN.
  • Upstate Medical Center Syracuse University, Syracuse, NY.
  • Anchorage Oncology Centre, Anchorage, AK.

ORCID-Profile: Rahul Banerjee, Hans Messersmith, Mohammad Ebraheem, Shaji Kumar, Samer Al Hadidi, Saurabh Zanwar, Benjamin Derman, Lisa K Hicks

Zitieren

APA

Banerjee, R., Messersmith, H., Ebraheem, M., Kumar, S., Seth, R., Subramanian, L., Al Hadidi, S., Zanwar, S., Cheung, M. C., Derman, B., & Hicks, L. K. (2026). Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-02399

Vancouver

Banerjee R, Messersmith H, Ebraheem M, Kumar S, Seth R, Subramanian L, et al. Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-02399

BibTeX
@article{Banerjee2026,
  author = {Banerjee, Rahul and Messersmith, Hans and Ebraheem, Mohammad and Kumar, Shaji and Seth, Rahul and Subramanian, Latha and Al Hadidi, Samer and Zanwar, Saurabh and Cheung, Matthew C and Derman, Benjamin and Hicks, Lisa K},
  title = {Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-26-02399}
}
Kostenlos starten →